HIGHLIGHTS
- who: Jinyoung Kim from the Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido StMary`s Hospital, The Catholic University of Korea have published the Article: Efficacy of bisphosphonate therapy on postmenopausal osteoporotic women with and without diabetes: a prospective trial, in the Journal: (JOURNAL) of 04/03/2022
- what: This study was conducted to provide evidence of the efficacy and safety of once-monthly ibandronate, at a 150 mg dose, in women with post-menopausal osteoporosis and T2DM. The study was performed in accordance with Declaration of Helsinki, and informed consent was obtained . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.